Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
981
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
982
-
983
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
984
-
985
-
986
-
987
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
988
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
989
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
990
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
991
-
992
-
993
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
994
-
995
-
996
-
997
-
998
-
999
Growth of certain cancer cell lines requires IRE1 but not its enzymatic activity.
Published 2025Subjects: -
1000